Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease

Publication date: Available online 2 November 2020Source: Prostaglandins & Other Lipid MediatorsAuthor(s): Hridayesh Prakash, Dilip Upadhyay, Obul Reddy Bandapalli, Aklank Jain, Burkhard Kleuser
Source: Prostaglandins and Other Lipid Mediators - Category: Lipidology Source Type: research
More News: COVID-19 | Lipidology | SARS